(BB) Société BIC - Ratings and Ratios
Pens, Lighters, Razors
BB EPS (Earnings per Share)
BB Revenue
Description: BB Société BIC
Société BIC SA is a French multinational company operating in the personal care products sub-industry, with a market capitalization of approximately €2.2 billion. The companys stock is listed on the Paris stock exchange under the ticker symbol BB.
The personal care products market is characterized by steady demand, driven by fundamental human needs, and is influenced by factors such as demographic trends, consumer preferences, and economic conditions. BICs performance is likely tied to its ability to innovate and maintain market share in a competitive landscape.
Key performance indicators (KPIs) to watch for BIC include revenue growth, gross margin, and return on equity (RoE), which currently stands at 14.44%. A stable or increasing RoE indicates effective use of shareholder capital. The price-to-earnings (P/E) ratio of 10.42 and forward P/E of 9.83 suggest that the stock may be undervalued relative to its earnings potential, although this requires further analysis in the context of industry averages and the companys growth prospects.
Economic drivers influencing BICs performance include consumer spending patterns, competition, and global economic trends. The companys low beta of 0.182 indicates relatively low volatility compared to the broader market, suggesting a defensive positioning that could be attractive in uncertain economic conditions.
To further assess the investment potential of BIC, it is essential to analyze its financial statements, including the income statement, balance sheet, and cash flow statement, to identify trends and anomalies. Additionally, examining the companys product portfolio, innovation pipeline, and competitive positioning will provide insights into its long-term growth prospects.
BB Stock Overview
| Market Cap in USD | 2,588m |
| Sub-Industry | Personal Care Products |
| IPO / Inception |
BB Stock Ratings
| Growth Rating | 6.51% |
| Fundamental | 65.4% |
| Dividend Rating | 84.9% |
| Return 12m vs S&P 500 | -18.6% |
| Analyst Rating | - |
BB Dividends
| Dividend Yield 12m | 8.17% |
| Yield on Cost 5y | 11.76% |
| Annual Growth 5y | 11.75% |
| Payout Consistency | 94.8% |
| Payout Ratio | 72.8% |
BB Growth Ratios
| Growth Correlation 3m | -25.8% |
| Growth Correlation 12m | -70% |
| Growth Correlation 5y | 82.9% |
| CAGR 5y | 6.81% |
| CAGR/Max DD 5y | 0.24 |
| Sharpe Ratio 12m | -0.16 |
| Alpha | -17.10 |
| Beta | 0.530 |
| Volatility | 20.33% |
| Current Volume | 27.5k |
| Average Volume 20d | 21k |
| Stop Loss | 51.8 (-3.2%) |
| Signal | -2.16 |
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (254.1m TTM) > 0 and > 6% of Revenue (6% = 165.1m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -8.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 29.00% (prev 33.58%; Δ -4.58pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.14 (>3.0%) and CFO 381.9m > Net Income 254.1m (YES >=105%, WARN >=100%) |
| Net Debt (-121.1m) to EBITDA (324.5m) ratio: -0.37 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.13 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (41.2m) change vs 12m ago -1.32% (target <= -2.0% for YES) |
| Gross Margin 49.71% (prev 60.49%; Δ -10.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 100.0% (prev 101.4%; Δ -1.41pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 19.26 (EBITDA TTM 324.5m / Interest Expense TTM 12.4m) >= 6 (WARN >= 3) |
Altman Z'' 6.35
| (A) 0.29 = (Total Current Assets 1.50b - Total Current Liabilities 703.3m) / Total Assets 2.74b |
| (B) 0.62 = Retained Earnings (Balance) 1.69b / Total Assets 2.74b |
| (C) 0.09 = EBIT TTM 239.7m / Avg Total Assets 2.75b |
| (D) 1.75 = Book Value of Equity 1.85b / Total Liabilities 1.06b |
| Total Rating: 6.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.44
| 1. Piotroski 6.0pt = 1.0 |
| 2. FCF Yield 1.95% = 0.97 |
| 3. FCF Margin 1.53% = 0.38 |
| 4. Debt/Equity 0.15 = 2.49 |
| 5. Debt/Ebitda 0.76 = 2.07 |
| 6. ROIC - WACC 1.01% = 1.27 |
| 7. RoE 14.44% = 1.20 |
| 8. Rev. Trend 29.29% = 1.46 |
| 9. Rev. CAGR 22.85% = 2.50 |
| 10. EPS Trend -6.04% = -0.15 |
| 11. EPS CAGR 22.42% = 2.24 |
What is the price of BB shares?
Over the past week, the price has changed by -1.65%, over one month by -2.55%, over three months by -1.19% and over the past year by -4.25%.
Is Société BIC a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BB is around 54.89 EUR . This means that BB is currently overvalued and has a potential downside of 2.6%.
Is BB a buy, sell or hold?
What are the forecasts/targets for the BB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 62.6 | 17% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 60.7 | 13.4% |
BB Fundamental Data Overview
Market Cap EUR = 2.22b (2.22b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 310.1m EUR (last quarter)
P/E Trailing = 12.7187
P/E Forward = 10.1729
P/S = 1.0408
P/B = 1.3331
P/EG = 4.99
Beta = 0.169
Revenue TTM = 2.75b EUR
EBIT TTM = 239.7m EUR
EBITDA TTM = 324.5m EUR
Long Term Debt = 120.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 126.0m EUR (from shortTermDebt, last quarter)
Debt = 246.0m EUR (Calculated: Short Term 126.0m + Long Term 120.0m)
Net Debt = -121.1m EUR (from netDebt column, last fiscal year)
Enterprise Value = 2.16b EUR (2.22b + Debt 246.0m - CCE 310.1m)
Interest Coverage Ratio = 19.26 (Ebit TTM 239.7m / Interest Expense TTM 12.4m)
FCF Yield = 1.95% (FCF TTM 42.0m / Enterprise Value 2.16b)
FCF Margin = 1.53% (FCF TTM 42.0m / Revenue TTM 2.75b)
Net Margin = 9.23% (Net Income TTM 254.1m / Revenue TTM 2.75b)
Gross Margin = 49.71% ((Revenue TTM 2.75b - Cost of Revenue TTM 1.38b) / Revenue TTM)
Tobins Q-Ratio = 1.17 (Enterprise Value 2.16b / Book Value Of Equity 1.85b)
Interest Expense / Debt = 5.06% (Interest Expense 12.4m / Debt 246.0m)
Taxrate = 28.76% (from yearly Income Tax Expense: 85.6m / 297.6m)
NOPAT = 170.7m (EBIT 239.7m * (1 - 28.76%))
Current Ratio = 2.13 (Total Current Assets 1.50b / Total Current Liabilities 703.3m)
Debt / Equity = 0.15 (Debt 246.0m / last Quarter total Stockholder Equity 1.68b)
Debt / EBITDA = 0.76 (Net Debt -121.1m / EBITDA 324.5m)
Debt / FCF = 5.86 (Debt 246.0m / FCF TTM 42.0m)
Total Stockholder Equity = 1.76b (last 4 quarters mean)
RoA = 9.29% (Net Income 254.1m, Total Assets 2.74b )
RoE = 14.44% (Net Income TTM 254.1m / Total Stockholder Equity 1.76b)
RoCE = 12.75% (Ebit 239.7m / (Equity 1.76b + L.T.Debt 120.0m))
RoIC = 8.55% (NOPAT 170.7m / Invested Capital 2.00b)
WACC = 7.53% (E(2.22b)/V(2.47b) * Re(7.97%)) + (D(246.0m)/V(2.47b) * Rd(5.06%) * (1-Tc(0.29)))
Shares Correlation 5-Years: -100.0 | Cagr: -1.85%
Discount Rate = 7.97% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈133.2m ; Y1≈164.3m ; Y5≈280.4m
Fair Price DCF = 115.7 (DCF Value 4.77b / Shares Outstanding 41.2m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 29.29 | Revenue CAGR: 22.85%
Rev Growth-of-Growth: -4.79
EPS Correlation: -6.04 | EPS CAGR: 22.42%
EPS Growth-of-Growth: -98.45